Port Jersey Logistics selected as Top 100 Supply Chain Partner by SupplyChainBrain

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Port Jersey Logistics (PJL), a leading public warehousing and distribution company, has been chosen for SupplyChainBrain's list of 100 Great Supply Chain Partners.  Now in its 11th year, the prestigious list highlights a select group of companies nominated by their own customers for exemplary supply chain service and logistics solutions.

SupplyChainBrain is the world’s most comprehensive supply chain management information resource, providing insight on emerging trends, technologies and best practices in the logistics and warehousing industries.

To gain inclusion on SupplyChainBrain’s Top 100 list, Port Jersey Logistics met and exceeded a range of third-party logistics criteria, including significant impact on customer efficiency, tailored service and overall supply chain performance. 

“It is an honor to be appreciated by our customers, so much so that they invested the time and effort into nominating us to our counterparts at SupplyChainBrain,” said Robert Russo, President of Port Jersey Logistics.  “This recognition validates our dedication to superior client service, and compels us to work even harder to deliver third-party logistics solutions that directly impact our customers’ businesses.”
 

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?